1,2-distearoylphosphatidylethanolamine and Carcinoma, Lewis Lung

1,2-distearoylphosphatidylethanolamine has been researched along with Carcinoma, Lewis Lung in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Abu Lila, AS; Ishida, T; Kiwada, H; Nawata, K; Shimizu, T	1

Other Studies

1 other study(ies) available for 1,2-distearoylphosphatidylethanolamine and Carcinoma, Lewis Lung

Article	Year
Use of polyglycerol (PG), instead of polyethylene glycol (PEG), prevents induction of the accelerated blood clearance phenomenon against long-circulating liposomes upon repeated administration. International journal of pharmaceutics, 2013, Nov-01, Volume: 456, Issue:1 Topics: Animals; Antineoplastic Agents; Carcinoma, Lewis Lung; Cell Line, Tumor; Doxorubicin; Glycerol; Immunoglobulin M; Liposomes; Male; Mice; Mice, Inbred C57BL; Phosphatidylethanolamines; Polyethylene Glycols; Polymers; Rats; Rats, Wistar; Tumor Burden	2013

Article

Year

Use of polyglycerol (PG), instead of polyethylene glycol (PEG), prevents induction of the accelerated blood clearance phenomenon against long-circulating liposomes upon repeated administration.

International journal of pharmaceutics, 2013, Nov-01, Volume: 456, Issue:1

Topics: Animals; Antineoplastic Agents; Carcinoma, Lewis Lung; Cell Line, Tumor; Doxorubicin; Glycerol; Immunoglobulin M; Liposomes; Male; Mice; Mice, Inbred C57BL; Phosphatidylethanolamines; Polyethylene Glycols; Polymers; Rats; Rats, Wistar; Tumor Burden

2013